Whilst the US Food and Drug Administration (FDA) has approved five drug therapies to treat obesity (orlistat, phentermine/topiramate, lorcaserin, naltrexone/bupropion, liraglutide), the European Medicines Agency (EMA) has approved only three drug therapies (orlistat, bupropion/naltrexone and liraglutide) [8] at the time of writing
Metabolomic data analysis We measured the concentrations of 54 metabolites and also evaluated the ratios of these metabolites (Supplementary Table 1)
Additional molecular regulatory mechanisms The inhibitory effect of GLP-1RAs on NF-B has been shown to suppress the proliferation of pancreatic cancer cells [66]
10.2147/TCRM.S104339 [DOI] [PMC free article] [PubMed] [Google Scholar] 16.Zendehdel K, Bahmanyar S, McCarthy S, Nyren O, Andersson B, Ye W
Browse all Peptides & GLP-1 education Consider this an independent, fair-balance editorial assessment
During the meeting with 36Kr, Yu Bai brought three mobile phones and a high-power power bank